REGULUS THERAPEUTICS INC's ticker is and the CUSIP is 75915K901. A total of 1 filers reported holding REGULUS THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $8,000 | -42.9% | 8,300 | 0.0% | 0.00% | – |
| Q1 2017 | $14,000 | -73.1% | 8,300 | -63.9% | 0.00% | -100.0% |
| Q4 2016 | $52,000 | -93.5% | 23,000 | -90.5% | 0.00% | -88.9% |
| Q3 2016 | $799,000 | +37.5% | 242,100 | +20.4% | 0.01% | +28.6% |
| Q2 2016 | $581,000 | -60.4% | 201,000 | -5.0% | 0.01% | -66.7% |
| Q1 2016 | $1,466,000 | -18.8% | 211,600 | +2.2% | 0.02% | 0.0% |
| Q4 2015 | $1,805,000 | +29.9% | 207,000 | -2.5% | 0.02% | +10.5% |
| Q3 2015 | $1,389,000 | -43.2% | 212,400 | -4.9% | 0.02% | -44.1% |
| Q2 2015 | $2,447,000 | -35.2% | 223,300 | +0.2% | 0.03% | -42.4% |
| Q1 2015 | $3,774,000 | +5.7% | 222,800 | +0.0% | 0.06% | +9.3% |
| Q4 2014 | $3,572,000 | +7665.2% | 222,700 | +3175.0% | 0.05% | +5300.0% |
| Q3 2014 | $46,000 | -4.2% | 6,800 | +13.3% | 0.00% | 0.0% |
| Q2 2014 | $48,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|